Lucy Abraham, Msc

Senior Director, HV&E Team Lead, Migraine
Pfizer R&D UK Ltd., Tadworth, Surrey
Surrey, England, United Kingdom

Lucy Abraham, MsC, Psychol, is a health economics and outcomes researcher with over 23 years of experience in the pharmaceutical industry, specializing in health technology appraisals and real-world evidence. Currently, she is the HTA Value and Evidence Team Lead for the global migraine franchise at Pfizer.

Disclosure information not submitted.

Presentation(s):

• P-072 - A retrospective cohort study comparing persistence between rimegepant and oral triptans for the acute treatment of migraine in the United States.

  POSTER ABSTRACT

• P-103 - Satisfaction with treatment outcomes in people with migraine receiving rimegepant or triptans: a descriptive analysis from a real-world migraine tracking app

  POSTER ABSTRACT